Skip to content

Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes

Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01411865
Enrollment
933789
Registered
2011-08-08
Start date
2011-08-31
Completion date
2011-10-31
Last updated
2014-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Diabetes Mellitus

Keywords

Pragmatic randomized controlled trial, Cardiovascular risk reduction, Knowledge translation, Clinical practice guidelines, Administrative databases

Brief summary

Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.

Detailed description

A cardiovascular disease Toolkit was developed by the Canadian Diabetes Association and mailed to family physician with the Spring/Summer 2009 edition of the newsletter, Canadian Diabetes. The Toolkit was packaged in a brightly-coloured box with Canadian Diabetes Association branding, and contained: 1) an introductory letter from the Chair of the practice guidelines' Dissemination and Implementation Committee; 2) an eight page summary of selected sections of the practice guidelines targeted towards primary care physicians; 3) a four page synopsis of the key guideline elements pertaining to cardiovascular disease risk; 4) a small double-sided laminated card with a simplified algorithm for cardiovascular risk assessment, vascular protection strategies and screening for cardiovascular disease; and 5) a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool and a list of recommended risk reduction strategies.

Interventions

OTHERToolkit

Cardiovascular Disease Toolkit mailed by the Canadian Diabetes Association to family physicians, accompanying the Spring/Summer 2009 edition of the quarterly newsletter, Canadian Diabetes. (Mailed in June 2009.) The Toolkit includes a summary of selected sections of the practice guidelines targeted towards primary care physicians; a synopsis of the key messages pertaining to cardiovascular disease risk; a laminated card with a simplified algorithm for cardiovascular risk assessment and treatment; and a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool.

OTHERControl

The Spring/Summer 2009 issue of the quarterly newsletter, Canadian Diabetes, mailed on its own. The Cardiovascular Toolkit was mailed with the May 2010 issue of the newsletter.

Sponsors

Institute for Clinical Evaluative Sciences
CollaboratorOTHER
Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Alive on 1 July 2009 with prevalent diabetes

Exclusion criteria

* Age \<= 39 * Residing in long-term care Secondary Analysis: * Analysis will be repeated using all people alive on 1 July 2009 without prevalent diabetes using the same

Design outcomes

Primary

MeasureTime frame
Death or non-fatal myocardial infarctionUp to 10 months

Secondary

MeasureTime frame
Death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for unstable angina or transient ischemic attackUp to 10 months
DeathUp to 10 months
Hospitalization for myocardial infarctionUp to 10 months
Hospitalization for myocardial infarction or unstable anginaUp to 10 months
Hospitalization for strokeUp to 10 months
Hospitalization for stroke or transient ischemic attackUp to 10 months
ElectrocardiogramUp to 10 months
Cardiac stress test or nuclear imagingUp to 10 months
Coronary angiographyUp to 10 months
Death, non-fatal myocardial infarction or non-fatal strokeUp to 10 months
Ambulatory cardiology or internal medicine visitUp to 10 months
Prescription for angiotensin converting enzyme inhibitor or angiotensin receptor blockerUp to 10 months
Prescription for at least one class of antihypertensive agentUp to 10 months
Prescription for at least two classes of antihypertensive agentsUp to 10 months
Prescription for at least three classes of antihypertensive agentsUp to 10 months
Prescription for statinUp to 10 months
Prescription for any glucose-lowering drugUp to 10 months
Prescription for insulinUp to 10 months
Prescription for nitrateUp to 10 months
Coronary revascularization procedureUp to 10 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026